Patents by Inventor Robert Havener
Robert Havener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12365432Abstract: A submersible vehicle is provided which is able to achieve six of freedom utilizing a combination of only two thrusters with no external control planes. Each of the two thrusters can include a plurality of ducts which can be selectively opened or closed, to varying degrees, to achieve six degrees of freedom for both control and propulsion.Type: GrantFiled: September 19, 2022Date of Patent: July 22, 2025Assignee: Tiburon Subsea Inc.Inventors: Timothy Taylor, Robert Havens
-
Patent number: 12317888Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: July 30, 2020Date of Patent: June 3, 2025Assignee: TRANSMEDICS, INCInventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer I. Khayal, Stanley Kyi, Ronald Taylor, Jr., Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed H. Hassanein
-
Patent number: 12207649Abstract: The disclosure provides for electrode systems and perfusion systems that may be configured to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems may maintain the heart in a beating state at, or near, normal physiological conditions; circulate oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure, and/or flow rate. These systems may include a pair of electrodes that may be placed epicardially on the right atrium and/or left ventricle of the explanted heart, and/or an electrode placed in the aortic blood path.Type: GrantFiled: December 26, 2023Date of Patent: January 28, 2025Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs
-
Patent number: 11917991Abstract: Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a beating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.Type: GrantFiled: May 21, 2019Date of Patent: March 5, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs
-
Patent number: 11856944Abstract: An ex-vivo lung solution for machine perfusion of donor lungs on OCS. The solution may be mixed with whole blood or packed red blood cells to form the OCS lung perfusion solution.Type: GrantFiled: July 20, 2022Date of Patent: January 2, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ihab Abdel Fattah, Paul Lezberg, Tamer I. Khayal, Robert Havener, Anas Abdelazim
-
Publication number: 20230357841Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: ApplicationFiled: January 27, 2023Publication date: November 9, 2023Inventors: Mark Aaron Behlke, John Robert Havens
-
Patent number: 11685630Abstract: An outdoor hose storage enclosure is an apparatus that securely retains a hose and facilitates the deployment and storage of said hose. The apparatus may include a storage housing and a storage lid. The storage housing serves to retain the hose readily accessible for easy retrieval of the hose. The storage lid serves to seal the storage housing to protect the hose from the environment and theft. The storage housing may include a first lateral panel, a second lateral panel, a front panel, a first attachment mechanism, a second attachment mechanism, a bottom panel, and a hose opening. The first lateral panel, the second lateral panel, the front panel, and the bottom panel form the structure of the storage housing. The first attachment mechanism and the second attachment mechanism enable the mounting of the apparatus to the desired surface. The hose opening facilitates the deployment and storage of the hose.Type: GrantFiled: September 15, 2021Date of Patent: June 27, 2023Inventor: Timothy Robert Havens
-
Publication number: 20230090682Abstract: A submersible vehicle is provided which is able to achieve six of freedom utilizing a combination of only two thrusters with no external control planes. Each of the two thrusters can include a plurality of ducts which can be selectively opened or closed, to varying degrees, to achieve six degrees of freedom for both control and propulsion.Type: ApplicationFiled: September 19, 2022Publication date: March 23, 2023Applicant: Tiburon Subsea Inc.Inventors: Timothy Taylor, Robert Havens
-
Patent number: 11566283Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: GrantFiled: October 15, 2016Date of Patent: January 31, 2023Assignee: Integrated DNA Technologies, Inc.Inventors: Mark Aaron Behlke, John Robert Havens
-
Patent number: 11566282Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: GrantFiled: October 15, 2016Date of Patent: January 31, 2023Assignee: INTEGRATED DNA TECHNOLOGIES, INC.Inventors: Mark Aaron Behlke, John Robert Havens, Mirna Jarosz, Zachary Zwirko, Doron Lipson, Frank Soo Juhn
-
Publication number: 20220081250Abstract: An outdoor hose storage enclosure is an apparatus that securely retains a hose and facilitates the deployment and storage of said hose. The apparatus may include a storage housing and a storage lid. The storage housing serves to retain the hose readily accessible for easy retrieval of the hose. The storage lid serves to seal the storage housing to protect the hose from the environment and theft. The storage housing may include a first lateral panel, a second lateral panel, a front panel, a first attachment mechanism, a second attachment mechanism, a bottom panel, and a hose opening. The first lateral panel, the second lateral panel, the front panel, and the bottom panel form the structure of the storage housing. The first attachment mechanism and the second attachment mechanism enable the mounting of the apparatus to the desired surface. The hose opening facilitates the deployment and storage of the hose.Type: ApplicationFiled: September 15, 2021Publication date: March 17, 2022Inventor: Timothy Robert Havens
-
Patent number: 10750738Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: April 8, 2008Date of Patent: August 25, 2020Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
-
Patent number: 10327443Abstract: Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a heating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.Type: GrantFiled: July 11, 2016Date of Patent: June 25, 2019Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs
-
Patent number: 10266889Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: GrantFiled: July 3, 2013Date of Patent: April 23, 2019Assignees: ROCHE FINANCE LTD, INTEGRATED DNA TECHNOLOGIES, INC.Inventors: Mark Aaron Behlke, John Robert Havens, Mirna Jarosz, Zachary Zwirko, Doron Lipson, Frank Soo Juhn
-
Patent number: 9814230Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: April 8, 2008Date of Patent: November 14, 2017Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Tom Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
-
Publication number: 20170114404Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: ApplicationFiled: October 15, 2016Publication date: April 27, 2017Inventors: Mark Aaron Behlke, John Robert Havens, Scott Daniel Rose
-
Publication number: 20170096706Abstract: The invention is directed to modified oligonucleotide compositions and methods for selectively reducing unwanted nucleic acid contaminants and enriching for desired nucleic acid targets from complex genomic nucleic acid mixtures for sequencing applications. The modified oligonucleotide compositions include one or more modified groups that increase the Tm of the resultant oligonucleotide composition.Type: ApplicationFiled: October 15, 2016Publication date: April 6, 2017Inventors: Mark Aaron Behlke, John Robert Havens, Scott Daniel Rose, Mirna Jarosz, Zachary Zwirko, Doron Lipson, Frank Soo Juhn
-
Patent number: 9516875Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: February 12, 2013Date of Patent: December 13, 2016Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab A. Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer I. Khayal, Stanley Kyi, Ron Taylor, Jr., Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed H. Hassanein
-
Patent number: 9462802Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: April 8, 2008Date of Patent: October 11, 2016Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Tom Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
-
Patent number: 9457179Abstract: Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a beating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.Type: GrantFiled: July 6, 2007Date of Patent: October 4, 2016Assignee: TRANSMEDICS, INC.Inventors: Waleed Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs